Incidence of oxaliplatin hypersensitivity reaction among colorectal cancer patients: A 5-year retrospective study.

Sirinoot Palapinyo Jettanong Klaewsongkram Virote Sriuranpong Nutthada Areepium

Published in: Pharmacy practice (2022)

Colorectal cancer patients treated with an oxaliplatin-based regimen with male gender, prior exposure to platinum-based chemotherapy and elevated eosinophil count have a greater risk of oxaliplatin related hypersensitivity reactions.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
drug induced
chronic kidney disease
prognostic factors
peritoneal dialysis
risk factors
mental health
radiation therapy
locally advanced
peripheral blood
rectal cancer